Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 07, 2025
ProBioGen announced the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for proteins as well as the completion of the construction phase of...
read more
Saturday, January 28, 2017
Vetter has begun operations in its expanded Visual Inspection and Logics Center located in Ravensburg. The enlargement, in which the company invested approximately 100 million euros ($107 million), bundles capacity for final product inspection and ...
read more
Tuesday, September 04, 2018
Olon S.p.A. announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.
read more
Wednesday, February 10, 2021
Avacta and Mologic have entered into a commercial partnership to accelerate to market Avacta’s AffiDX SARS-CoV-2 lateral flow rapid antigen test.
read more
PerkinElmer announced the launch of PerkinElmer Genetics’ clinical genomics services.
read more
Delpharm announced that it has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville.
read more
1Elevan Biopharmaceuticals has announced its relocation from California to Fishers, Indiana, establishing its new headquarters in the Fishers Life Sciences and Innovation Park. The move represents a $7 million investment in a next-generation facility...
read more
Wednesday, December 18, 2019
Pfenex has earned a $15 million development milestone under its development and license agreement with Jazz Pharmaceuticals.
read more
Bioanalytical Systems, Inc. (BASi) has announced financial results for the third quarter and first nine months of fiscal 2016.
read more
Cambrex Corporation announced it will expand pilot plant capabilities at its High Point, NC facility with the installation of a fourth reactor suite.
read more
CEL-SCI has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.
read more
Dyadic International, Inc. a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of ...
read more
Charles River Laboratories announced that it has completed the acquisition of Vigene Biosciences, Inc. for $292.5 million. In addition to the initial purchase price, the transaction includes additional payments of up to $57.5 million, contingent on ...
read more
Tuesday, December 09, 2025
Andelyn Biosciences has partnered with Jaguar Gene Therapy to perform late-stage Process Performance Qualification (PPQ) manufacturing of JAG201, an investigational gene therapy targeting SHANK3 haploinsufficiency which is clinically diagnosed as ...
read more
Formedix has announced the expansion of its development and test teams.
read more